Factor XII
Factor XII
Factor XII, also known as Hageman factor (pronounced: HAY-ge-man), is a protein that plays a crucial role in the human body's blood clotting process, also known as coagulation.
Etymology
The protein was named after John Hageman, the patient in whom it was first discovered.
Function
Factor XII is part of the intrinsic pathway of blood coagulation. It is activated by contact with negatively charged surfaces, a process known as contact activation. Once activated, Factor XII triggers a series of reactions that ultimately lead to the formation of a blood clot.
Related Terms
- Coagulation: The process by which blood changes from a liquid to a gel, forming a clot.
- Intrinsic pathway: One of two major pathways in the coagulation cascade, it is initiated within the blood itself by the activation of Factor XII.
- Contact activation: The process by which Factor XII is activated, initiating the intrinsic pathway of coagulation.
- Blood clot: A gel-like mass formed by platelets and fibrin in the blood to stop bleeding.
Clinical Significance
Deficiency of Factor XII does not cause abnormal bleeding, unlike deficiencies of other clotting factors. However, it can lead to a prolonged activated partial thromboplastin time (aPTT) test, which measures the time it takes for blood to clot.
Factor XII deficiency is a rare genetic disorder that is usually discovered during routine blood tests. It is typically not treated, as it does not cause any significant health problems.
External links
- Medical encyclopedia article on Factor XII
- Wikipedia's article - Factor XII
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski